Fine mapping and functional analysis of the multiple sclerosis risk gene CD6
Standard
Fine mapping and functional analysis of the multiple sclerosis risk gene CD6. / Swaminathan, Bhairavi; Cuapio, Angélica; Alloza, Iraide; Matesanz, Fuencisla; Alcina, Antonio; García-Barcina, Maria; Fedetz, Maria; Fernández, Oscar; Lucas, Miguel; Orpez, Teresa; Pinto-Medel, M Jesus; Otaegui, David; Olascoaga, Javier; Urcelay, Elena; Ortiz, Miguel A; Arroyo, Rafael; Oksenberg, Jorge R; Antigüedad, Alfredo; Tolosa, Eva; Vandenbroeck, Koen.
in: PLOS ONE, Jahrgang 8, Nr. 4, 01.01.2013, S. e62376.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Fine mapping and functional analysis of the multiple sclerosis risk gene CD6
AU - Swaminathan, Bhairavi
AU - Cuapio, Angélica
AU - Alloza, Iraide
AU - Matesanz, Fuencisla
AU - Alcina, Antonio
AU - García-Barcina, Maria
AU - Fedetz, Maria
AU - Fernández, Oscar
AU - Lucas, Miguel
AU - Orpez, Teresa
AU - Pinto-Medel, M Jesus
AU - Otaegui, David
AU - Olascoaga, Javier
AU - Urcelay, Elena
AU - Ortiz, Miguel A
AU - Arroyo, Rafael
AU - Oksenberg, Jorge R
AU - Antigüedad, Alfredo
AU - Tolosa, Eva
AU - Vandenbroeck, Koen
PY - 2013/1/1
Y1 - 2013/1/1
N2 - CD6 has recently been identified and validated as risk gene for multiple sclerosis (MS), based on the association of a single nucleotide polymorphism (SNP), rs17824933, located in intron 1. CD6 is a cell surface scavenger receptor involved in T-cell activation and proliferation, as well as in thymocyte differentiation. In this study, we performed a haptag SNP screen of the CD6 gene locus using a total of thirteen tagging SNPs, of which three were non-synonymous SNPs, and replicated the recently reported GWAS SNP rs650258 in a Spanish-Basque collection of 814 controls and 823 cases. Validation of the six most strongly associated SNPs was performed in an independent collection of 2265 MS patients and 2600 healthy controls. We identified association of haplotypes composed of two non-synonymous SNPs [rs11230563 (R225W) and rs2074225 (A257V)] in the 2(nd) SRCR domain with susceptibility to MS (P max(T) permutation = 1×10(-4)). The effect of these haplotypes on CD6 surface expression and cytokine secretion was also tested. The analysis showed significantly different CD6 expression patterns in the distinct cell subsets, i.e. - CD4(+) naïve cells, P = 0.0001; CD8(+) naïve cells, P<0.0001; CD4(+) and CD8(+) central memory cells, P = 0.01 and 0.05, respectively; and natural killer T (NKT) cells, P = 0.02; with the protective haplotype (RA) showing higher expression of CD6. However, no significant changes were observed in natural killer (NK) cells, effector memory and terminally differentiated effector memory T cells. Our findings reveal that this new MS-associated CD6 risk haplotype significantly modifies expression of CD6 on CD4(+) and CD8(+) T cells.
AB - CD6 has recently been identified and validated as risk gene for multiple sclerosis (MS), based on the association of a single nucleotide polymorphism (SNP), rs17824933, located in intron 1. CD6 is a cell surface scavenger receptor involved in T-cell activation and proliferation, as well as in thymocyte differentiation. In this study, we performed a haptag SNP screen of the CD6 gene locus using a total of thirteen tagging SNPs, of which three were non-synonymous SNPs, and replicated the recently reported GWAS SNP rs650258 in a Spanish-Basque collection of 814 controls and 823 cases. Validation of the six most strongly associated SNPs was performed in an independent collection of 2265 MS patients and 2600 healthy controls. We identified association of haplotypes composed of two non-synonymous SNPs [rs11230563 (R225W) and rs2074225 (A257V)] in the 2(nd) SRCR domain with susceptibility to MS (P max(T) permutation = 1×10(-4)). The effect of these haplotypes on CD6 surface expression and cytokine secretion was also tested. The analysis showed significantly different CD6 expression patterns in the distinct cell subsets, i.e. - CD4(+) naïve cells, P = 0.0001; CD8(+) naïve cells, P<0.0001; CD4(+) and CD8(+) central memory cells, P = 0.01 and 0.05, respectively; and natural killer T (NKT) cells, P = 0.02; with the protective haplotype (RA) showing higher expression of CD6. However, no significant changes were observed in natural killer (NK) cells, effector memory and terminally differentiated effector memory T cells. Our findings reveal that this new MS-associated CD6 risk haplotype significantly modifies expression of CD6 on CD4(+) and CD8(+) T cells.
KW - Adult
KW - Antigens, CD
KW - Antigens, Differentiation, T-Lymphocyte
KW - CD4-Positive T-Lymphocytes
KW - CD8-Positive T-Lymphocytes
KW - Chromosome Mapping
KW - Cluster Analysis
KW - Cytokines
KW - European Continental Ancestry Group
KW - Female
KW - Gene Order
KW - Genetic Loci
KW - Genetic Predisposition to Disease
KW - Haplotypes
KW - Humans
KW - Linkage Disequilibrium
KW - Lymphocyte Activation
KW - Male
KW - Multiple Sclerosis
KW - Polymorphism, Single Nucleotide
KW - Protein Interaction Domains and Motifs
KW - Spain
KW - Young Adult
U2 - 10.1371/journal.pone.0062376
DO - 10.1371/journal.pone.0062376
M3 - SCORING: Journal article
C2 - 23638056
VL - 8
SP - e62376
JO - PLOS ONE
JF - PLOS ONE
SN - 1932-6203
IS - 4
ER -